相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Tumour CD274 (PD-L1) expression and T cells in colorectal cancer
Yohei Masugi et al.
GUT (2017)
Clinicopathologic profile, immunophenotype, and genotype of CD274 (PD-L1)-positive colorectal carcinomas
Shingo Inaguma et al.
MODERN PATHOLOGY (2017)
Prognostic significance of PD-L1 in solid tumor An updated meta-analysis
Qianqian Wang et al.
MEDICINE (2017)
Prognostic value of PD-L1 expression in tumor infiltrating immune cells in cancers: A meta-analysis
Tiancheng Zhao et al.
PLOS ONE (2017)
Prognostic implication of CD274 (PD-L1) protein expression in tumor-infiltrating immune cells for microsatellite unstable and stable colorectal cancer
Kyu Sang Lee et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2017)
Expression of CXCR-4 and IDO in human colorectal cancer: An immunohistochemical approach
Masaichi Ogawa et al.
MOLECULAR AND CLINICAL ONCOLOGY (2017)
Characterisation of PD-L1-positive subsets of microsatellite-unstable colorectal cancers
Jung Ho Kim et al.
BRITISH JOURNAL OF CANCER (2016)
Lymphocyte-activation gene-3, an important immune checkpoint in cancer
Yayi He et al.
CANCER SCIENCE (2016)
Programmed cell death-ligand 1 expression is associated with a favourable immune microenvironment and better overall survival in stage I pulmonary squamous cell carcinoma
Ching-Yao Yang et al.
EUROPEAN JOURNAL OF CANCER (2016)
PD-L1 expression is associated with tumor-infiltrating T cells and favorable prognosis in high-grade serous ovarian cancer
John R. Webb et al.
GYNECOLOGIC ONCOLOGY (2016)
The role of PD-L1 expression as a predictive biomarker in advanced non-small-cell lung cancer: a network meta-analysis
Pedro N. Aguiar et al.
IMMUNOTHERAPY (2016)
Prognostic Role of Programmed Death Ligand-1 Expression in Breast Cancer: A Systematic Review and Meta-Analysis
Xue Li et al.
TARGETED ONCOLOGY (2016)
Prognostic and predictive value of tumor-infiltrating lymphocytes for clinical therapeutic research in patients with non-small cell lung cancer
Dong-Qiang Zeng et al.
ONCOTARGET (2016)
PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor for head and neck cancer patients
Hye Ryun Kim et al.
SCIENTIFIC REPORTS (2016)
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
D. T. Le et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
The Microsatellite Instable Subset of Colorectal Cancer Is a Particularly Good Candidate for Checkpoint Blockade Immunotherapy
Yanping Xiao et al.
CANCER DISCOVERY (2015)
The Vigorous Immune Microenvironment of Microsatellite Instable Colon Cancer Is Balanced by Multiple Counter-Inhibitory Checkpoints
Nicolas J. Llosa et al.
CANCER DISCOVERY (2015)
CD25 Identifies a Subset of CD4+FoxP3- TIL That Are Exhausted Yet Prognostically Favorable in Human Ovarian Cancer
Ronald J. deLeeuw et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
Matthew M. Gubin et al.
NATURE (2014)
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
Roy S. Herbst et al.
NATURE (2014)
Chemotherapy of MMR-deficient colorectal cancer
N. Devaud et al.
FAMILIAL CANCER (2013)
Indoleamine 2,3-dioxygenase, a new prognostic marker in sentinel lymph nodes of melanoma patients
Reinhart Speeckaert et al.
EUROPEAN JOURNAL OF CANCER (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Indoleamine 2,3-Dioxygenase Is It an Immune Suppressor?
Hatem Soliman et al.
CANCER JOURNAL (2010)
Mismatch repair deficient colorectal cancer in the era of personalized treatment
Madeleine Hewish et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer
Shuji Ogino et al.
GUT (2009)
Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer
Khalid I. Al-Shibli et al.
CLINICAL CANCER RESEARCH (2008)
Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer:: Effect on tumor-infiltrating T cells
G Brandacher et al.
CLINICAL CANCER RESEARCH (2006)
Concurrent infiltration by CD8+ T cells and CD4+ T cells is a favourable prognostic factor in non-small-cell lung carcinoma
K Hiraoka et al.
BRITISH JOURNAL OF CANCER (2006)
分享论文
